BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37648439)

  • 1. Long-term effectiveness of a cognitive behavioural therapy (CBT) in the management of fatigue in patients with relapsing remitting multiple sclerosis (RRMS): a multicentre, randomised, open-label, controlled trial versus standard care.
    Gay MC; Cassedanne F; Barbot F; Vaugier I; Thomas S; Manchon E; Bensmail D; Blanchere M; Heinzlef O
    J Neurol Neurosurg Psychiatry; 2024 Jan; 95(2):158-166. PubMed ID: 37648439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
    Thomas S; Thomas PW; Kersten P; Jones R; Green C; Nock A; Slingsby V; Smith AD; Baker R; Galvin KT; Hillier C
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1092-9. PubMed ID: 23695501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing non-inferiority of blended versus face-to-face cognitive behavioural therapy for severe fatigue in patients with multiple sclerosis and the effectiveness of blended booster sessions aimed at improving long-term outcome following both therapies: study protocol for two observer-blinded randomized clinical trials.
    Houniet-de Gier M; Beckerman H; van Vliet K; Knoop H; de Groot V
    Trials; 2020 Jan; 21(1):98. PubMed ID: 31959235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
    Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
    Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis: a randomized controlled trial.
    Khodaie F; Naser Moghadasi A; Kazemi AH; Zhao B
    Acupunct Med; 2023 Aug; 41(4):199-205. PubMed ID: 36722418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
    Thomas PW; Thomas S; Kersten P; Jones R; Slingsby V; Nock A; Davies Smith A; Baker R; Galvin KT; Hillier C
    BMC Neurol; 2014 May; 14():109. PubMed ID: 24886398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis.
    Pöttgen J; Moss-Morris R; Wendebourg JM; Feddersen L; Lau S; Köpke S; Meyer B; Friede T; Penner IK; Heesen C; Gold SM
    J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):970-976. PubMed ID: 29549193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue.
    Moss-Morris R; McCrone P; Yardley L; van Kessel K; Wills G; Dennison L
    Behav Res Ther; 2012 Jun; 50(6):415-21. PubMed ID: 22516321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a blended booster programme for the long-term outcome of cognitive behavioural therapy for MS-related fatigue: A randomized controlled trial.
    de Gier M; Beckerman H; Twisk JW; Knoop H; de Groot V
    Mult Scler; 2024 Jan; 30(1):71-79. PubMed ID: 38018811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of Bio-Electromagnetic-Energy Regulation therapy on fatigue in patients with multiple sclerosis.
    Haase R; Piatkowski J; Ziemssen T
    Altern Ther Health Med; 2011; 17(6):22-8. PubMed ID: 22314716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ).
    Thomas S; Kersten P; Thomas PW; Slingsby V; Nock A; Jones R; Davies Smith A; Galvin KT; Baker R; Hillier C
    BMJ Open; 2015 Oct; 5(10):e008274. PubMed ID: 26486976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.
    O'Dowd H; Gladwell P; Rogers CA; Hollinghurst S; Gregory A
    Health Technol Assess; 2006 Oct; 10(37):iii-iv, ix-x, 1-121. PubMed ID: 17014748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
    Goldstein LH; Robinson EJ; Pilecka I; Perdue I; Mosweu I; Read J; Jordan H; Wilkinson M; Rawlings G; Feehan SJ; Callaghan H; Day E; Purnell J; Baldellou Lopez M; Brockington A; Burness C; Poole NA; Eastwood C; Moore M; Mellers JD; Stone J; Carson A; Medford N; Reuber M; McCrone P; Murray J; Richardson MP; Landau S; Chalder T
    Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive behavioral therapy positively affects fatigue in patients with multiple sclerosis: Results of a randomized controlled trial.
    van den Akker LE; Beckerman H; Collette EH; Twisk JW; Bleijenberg G; Dekker J; Knoop H; de Groot V;
    Mult Scler; 2017 Oct; 23(11):1542-1553. PubMed ID: 28528567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for relapsing-remitting multiple sclerosis.
    He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for fatigue in inflammatory bowel disease.
    Farrell D; Artom M; Czuber-Dochan W; Jelsness-Jørgensen LP; Norton C; Savage E
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012005. PubMed ID: 32297974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized controlled pilot trial.
    Alketbi A; Basit S; Hamza N; Walton LM; Moustafa IM
    PLoS One; 2021; 16(11):e0258752. PubMed ID: 34748549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.